Skip to content
healthcare.dev

ETRAVIRINE

NDC 69315-286, ETRAVIRINE, tablet, from Leading Pharma, LLC.

Product NDC
69315-286
Status
Listed
Labeler
Leading Pharma, LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA215402
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69315-286 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ETRAVIRINE200 mg/1

Pharmacologic classes

Cytochrome P450 2C19 Inhibitors [MoA]; Cytochrome P450 2C9 Inhibitors [MoA]; Cytochrome P450 3A Inducers [MoA]; Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Non-Nucleoside Analog [EXT]; Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]

Package NDCNDC-11Package
69315-286-066931502860660 TABLET in 1 BOTTLE (69315-286-06)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/48ffeac8-38e8-4007-903a-dbffce25d679
  • NADAC price for package 69315028606

    GET /v1/drugs/nadac/69315028606

Use it

Look up 69315-286 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69315-286 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69315-286. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.